Search

Owing to their remarkable and adjustable optoelectronic properties, halide perovskites (HPs) have been regarded as a class of promising materials for various optoelectronic applications based on different energy conversion reactions, including photovoltaic cell, photocatalysis, electrocatalysis, and photoelectrochemical (PEC) systems. However, the low stability of HPs upon exposure to ambient conditions (e.g., water, heat, light, electricity) greatly hinders the practical applications of HPs. In the past few years, significant efforts have been devoted to enhancing the eventual stability of the perovskite‐based optoelectronic systems, mainly focusing on delivering improvements in the stabilities of halide perovskite materials and the relevant operation conditions of optoelectronic systems, which deserve in‐depth and systematic summaries. In this comprehensive review, the in‐depth environment‐induced decomposition mechanisms of typical HPs are elucidated. Simultaneously, the strategies for addressing the instability issues of halide perovskite materials are critically reviewed, including dimension control, compositional engineering, ligand passivation, and encapsulation engineering. Furthermore, the photoelectric applications based on the modified HPs and operation conditions are discussed systematically. In the last part of this review, future perspectives and outlooks toward the stability of HPs and their photoelectric applications are envisaged respectively. [ABSTRACT FROM AUTHOR]

X‐ray radiography, playing a crucial role in the daily life of humans, extends the application landscapes of perovskites. Lead halide perovskites remain superior candidates because of strong X‐ray absorption and effective conversion of X‐ray to visible photons. Unfortunately, the perovskites exhibiting efficient band‐edge emission (3D, quasi‐2D or 2D) usually suffer from severe self‐absorption, while the perovskites showing broadband emission with large Stokes shift (0D, 1D or 2D) usually have low quantum yield, long afterglow or poor solution‐processability. Halide‐intercalated perovskites, with incorporated halides in organic layers, exhibit attractive optoelectronic properties due to reduced confinement of excitons, but their development falls far behind due to limited molecular design strategies and wet‐chemistry methods. Here, the use of universal‐wet‐chemistry‐synthesized novel halide‐intercalated perovskites as an efficient X‐ray scintillator for X‐ray imaging is reported. These novel perovskites exhibit superior luminescence by exploiting both free and self‐trapped excitons via halide intercalation. Accordingly, such perovskite scintillators present higher radioluminescence performance compared with conventional perovskite scintillators through enhanced radiative recombination and suppressed self‐absorption simultaneously. With such a scintillator screen, high‐performance X‐ray imaging is demonstrated. The results not only represent a universal synthesis route for the development of perovskites, but also provide valuable guidance for high‐performance X‐ray radiography. [ABSTRACT FROM AUTHOR]

Background: Metabolic derangements and systemic inflammation are related to the progression of colorectal cancer (CRC) and the prognoses of these patients. The survival of stage II and III CRC patients existed considerable heterogeneity highlighting the urgent need for new prediction models. This study aimed to develop and validate prognostic nomograms based on preoperative serum liver enzyme as well as evaluate the clinical utility. Methods: A total of 4014 stage II/III primary CRC patients pathologically diagnosed from January 2007 to December 2013 were included in this study. These patients were randomly divided into a training set (n = 2409) and a testing set (n = 1605). Univariate and multivariate Cox analyses were used to select the independent factors for predicting overall survival (OS) and disease-free survival (DFS) of stage II/III CRC patients. Next, nomograms were constructed and validated to predict the OS and DFS of individual CRC patients. The clinical utility of nomograms, tumor-node-metastasis (TNM), and the American Joint Committee on Cancer (AJCC) system was evaluated using time-dependent ROC and decision curve analyses. Results: Among seven preoperative serum liver enzyme markers, aspartate aminotransferase-to-alanine aminotransferase ratio (De Ritis ratio) was identified as an independent factor for predicting both OS and DFS of stage II/III CRC patients. The nomograms incorporated De Ritis ratio and significant clinicopathological features achieved good accuracy in terms of OS and DFS prediction, with C-index of 0.715 and 0.692, respectively. The calibration curve showed good agreement between prediction by nomogram and actual observation. The results of time-dependent ROC and decision curve analyses suggested that the nomograms had improved discrimination and greater clinical benefits compared with TNM and AJCC staging. Conclusions: De Ritis ratio was an independent predictor in predicting both the OS and DFS of patients with stage II/III CRC. Nomograms based on De Ritis ratio and clinicopathological features showed better clinical utility, which is expected to help clinicians develop appropriate individual treatment strategies for patients with stage II /III CRC. [ABSTRACT FROM AUTHOR]

p–n Junctions have been widely used in the construction of high-performance TiO2 ultraviolet photoelectric detector devices, especially NiO/TiO2 heterostructures. In this work, two devices with different structures were constructed to investigate the effects of the growth of NiO above (S-TN) and below (D-NT) the TiO2 array on the device performance, and the D-NT device showed better performance. The D-NT device exhibited a lower dark current, with a decrease of approximately an order of magnitude compared with S-TN PD and TiO2 nanoarray (NA) PDs. The D-NT heterojunction device demonstrated a large on–off ratio of 5.4 × 104, a high detection sensitivity of 1.44 × 1014 Jones, and a fast photoresponse time of 2 s under UV light illumination. Interestingly, the D-NT device also displayed self-powered performance, and its photoresponse time was 0.1 s. The dense and uniform NiO film deposited on the FTO substrate not only forms a built-in potential field with the TiO2 NAs, but it also provides greater uniformity and stability to this built-in potential field compared to a NiO layer spin-coated on TiO2 NAs, which may be the main reason for the high performance of the D-NT photodetector. The device in which NiO was grown below the TiO2 array provides a fundamental basis for the future development of all-solid-state photodetectors. [ABSTRACT FROM AUTHOR]

Simple Summary: Inflammation plays a critical role in the progression of colorectal cancer (CRC). Peripheral blood cell counts could reflect the extent of systemic inflammation and are readily available in clinical practice. The aim of our study was to construct a novel prognostic inflammatory index (PII) by integrating the blood cell counts associated with prognosis and to evaluate and validate the prognostic value of PII in two independent CRC cohorts. Multivariate Cox analyses in the training cohort of 4154 CRC patients indicated that high OS-PII (>4.27) and high DFS-PII (>4.47) were significantly associated with worse OS (HR: 1.330, p < 0.001) and worse DFS (HR: 1.366, p < 0.001), which has been validated in the external validation cohort of 5161 patients. Both OS-PII and DFS-PII have a stable prognostic performance at various follow-up times, and the nomograms based on OS-PII and DFS-PII achieved good accuracy in personalized survival prediction of patients with CRC. Host inflammation is a critical component of tumor progression and its status can be indicated by peripheral blood cell counts. We aimed to construct a comprehensively prognostic inflammatory index (PII) based on preoperative peripheral blood cell counts and further evaluate its prognostic value for patients with colorectal cancer (CRC). A total of 9315 patients with stage II and III CRC from training and external validation cohorts were included. The PII was constructed by integrating all the peripheral blood cell counts associated with prognosis in the training cohort. Cox analyses were performed to evaluate the association between PII and overall survival (OS) and disease-free survival (DFS). In the training cohort, multivariate Cox analyses indicated that high OS-PII (>4.27) was significantly associated with worse OS (HR: 1.330, 95% CI: 1.189–1.489, p < 0.001); and high DFS-PII (>4.47) was significantly associated with worse DFS (HR: 1.366, 95% CI: 1.206–1.548, p < 0.001). The prognostic values of both OS-PII and DFS-PII were validated in the external validation cohort. The nomograms achieved good accuracy in predicting both OS and DFS. Time-dependent ROC analyses showed that both OS-PII and DFS-PII have a stable prognostic performance at various follow-up times. The prognostic value of tumor-node-metastasis staging could be enhanced by combining it with either OS-PII or DFS-PII. We demonstrated that PIIs are independent prognostic predictors for CRC patients, and the nomograms based on PIIs can be recommended for personalized survival prediction of patients with CRC. [ABSTRACT FROM AUTHOR]